Bevacizumab and dose-intense temozolomide in recurrent high-grade glioma

J.J.C. Verhoeff; C. Lavini; M.E. van Linde; L.J.A. Stalpers; C.B.L.M. Majoie; J.C. Reijneveld; W.R. van Furth; D.J. Richel

doi:10.1093/annonc/mdp591

Bevacizumab and dose-intense temozolomide in recurrent high-grade glioma

J.J.C. Verhoeff, C. Lavini, M.E. van Linde, L.J.A. Stalpers, C.B.L.M. Majoie, J.C. Reijneveld, W.R. van Furth, D.J. Richel

Research output: Contribution to journal › Article › Academic › peer-review

Original language	Undefined/Unknown
Pages (from-to)	1723-1727
Journal	Annals of Oncology
Volume	21
Issue number	8
DOIs	https://doi.org/10.1093/annonc/mdp591
Publication status	Published - 2010

Access to Document

10.1093/annonc/mdp591

Cite this

@article{f928f1dd16214bb59f91340e5b58ce41,

title = "Bevacizumab and dose-intense temozolomide in recurrent high-grade glioma",

author = "J.J.C. Verhoeff and C. Lavini and {van Linde}, M.E. and L.J.A. Stalpers and C.B.L.M. Majoie and J.C. Reijneveld and {van Furth}, W.R. and D.J. Richel",

year = "2010",

doi = "10.1093/annonc/mdp591",

language = "Undefined/Unknown",

volume = "21",

pages = "1723--1727",

journal = "Annals of Oncology",

issn = "0923-7534",

publisher = "Oxford University Press",

number = "8",

}

TY - JOUR

T1 - Bevacizumab and dose-intense temozolomide in recurrent high-grade glioma

AU - Verhoeff, J.J.C.

AU - Lavini, C.

AU - van Linde, M.E.

AU - Stalpers, L.J.A.

AU - Majoie, C.B.L.M.

AU - Reijneveld, J.C.

AU - van Furth, W.R.

AU - Richel, D.J.

PY - 2010

Y1 - 2010

U2 - 10.1093/annonc/mdp591

DO - 10.1093/annonc/mdp591

M3 - Article

C2 - 20064829

VL - 21

SP - 1723

EP - 1727

JO - Annals of Oncology

JF - Annals of Oncology

SN - 0923-7534

IS - 8

ER -